263 related articles for article (PubMed ID: 30964323)
1. The Carcinogenome Project: In Vitro Gene Expression Profiling of Chemical Perturbations to Predict Long-Term Carcinogenicity.
Li A; Lu X; Natoli T; Bittker J; Sipes NS; Subramanian A; Auerbach S; Sherr DH; Monti S
Environ Health Perspect; 2019 Apr; 127(4):47002. PubMed ID: 30964323
[TBL] [Abstract][Full Text] [Related]
2. Genomic models of short-term exposure accurately predict long-term chemical carcinogenicity and identify putative mechanisms of action.
Gusenleitner D; Auerbach SS; Melia T; Gómez HF; Sherr DH; Monti S
PLoS One; 2014; 9(7):e102579. PubMed ID: 25058030
[TBL] [Abstract][Full Text] [Related]
3. Assessing compound carcinogenicity in vitro using connectivity mapping.
Caiment F; Tsamou M; Jennen D; Kleinjans J
Carcinogenesis; 2014 Jan; 35(1):201-7. PubMed ID: 23940306
[TBL] [Abstract][Full Text] [Related]
4. Network-based analysis of transcriptional profiles from chemical perturbations experiments.
Mulas F; Li A; Sherr DH; Monti S
BMC Bioinformatics; 2017 Mar; 18(Suppl 5):130. PubMed ID: 28361664
[TBL] [Abstract][Full Text] [Related]
5. Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.
Waters MD; Jackson M; Lea I
Mutat Res; 2010 Dec; 705(3):184-200. PubMed ID: 20399889
[TBL] [Abstract][Full Text] [Related]
6. Toxicogenomics applied to in vitro carcinogenicity testing with Balb/c 3T3 cells revealed a gene signature predictive of chemical carcinogens.
Rohrbeck A; Salinas G; Maaser K; Linge J; Salovaara S; Corvi R; Borlak J
Toxicol Sci; 2010 Nov; 118(1):31-41. PubMed ID: 20713471
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of toxicogenomics approaches for assessing the risk of nongenotoxic carcinogenicity in rat liver.
Eichner J; Wrzodek C; Römer M; Ellinger-Ziegelbauer H; Zell A
PLoS One; 2014; 9(5):e97678. PubMed ID: 24828355
[TBL] [Abstract][Full Text] [Related]
8. Alternative Carcinogenicity Screening Assay Using Colon Cancer Stem Cells: A Quantitative PCR (qPCR)-Based Prediction System for Colon Carcinogenesis.
Bak Y; Jang HJ; Shin JW; Kim SJ; Chun HW; Seo JH; No SH; Chae JI; Son DH; Lee SY; Hong J; Yoon DY
J Microbiol Biotechnol; 2018 Apr; 28(4):645-651. PubMed ID: 29539880
[TBL] [Abstract][Full Text] [Related]
9. Exploiting microRNA and mRNA profiles generated in vitro from carcinogen-exposed primary mouse hepatocytes for predicting in vivo genotoxicity and carcinogenicity.
Rieswijk L; Brauers KJ; Coonen ML; Jennen DG; van Breda SG; Kleinjans JC
Mutagenesis; 2016 Sep; 31(5):603-15. PubMed ID: 27338304
[TBL] [Abstract][Full Text] [Related]
10. Dynamically monitoring cellular γ-H2AX reveals the potential of carcinogenicity evaluation for genotoxic compounds.
Qu M; Xu H; Li W; Chen J; Zhang Y; Xu B; Li Z; Liu T; Guo L; Xie J
Arch Toxicol; 2021 Nov; 95(11):3559-3573. PubMed ID: 34510228
[TBL] [Abstract][Full Text] [Related]
11. An improved model of predicting hepatocarcinogenic potential in rats by using gene expression data.
Yamada F; Sumida K; Saito K
J Appl Toxicol; 2016 Feb; 36(2):296-308. PubMed ID: 26198598
[TBL] [Abstract][Full Text] [Related]
12. Using microRNA profiles to predict and evaluate hepatic carcinogenic potential.
Gooderham NJ; Koufaris C
Toxicol Lett; 2014 Jul; 228(2):127-32. PubMed ID: 24793013
[TBL] [Abstract][Full Text] [Related]
13. Inter-laboratory study of human in vitro toxicogenomics-based tests as alternative methods for evaluating chemical carcinogenicity: a bioinformatics perspective.
Herwig R; Gmuender H; Corvi R; Bloch KM; Brandenburg A; Castell J; Ceelen L; Chesne C; Doktorova TY; Jennen D; Jennings P; Limonciel A; Lock EA; McMorrow T; Phrakonkham P; Radford R; Slattery C; Stierum R; Vilardell M; Wittenberger T; Yildirimman R; Ryan M; Rogiers V; Kleinjans J
Arch Toxicol; 2016 Sep; 90(9):2215-2229. PubMed ID: 26525393
[TBL] [Abstract][Full Text] [Related]
14. CARCINOscreen®: New short-term prediction method for hepatocarcinogenicity of chemicals based on hepatic transcript profiling in rats.
Matsumoto H; Saito F; Takeyoshi M
J Toxicol Sci; 2014; 39(5):725-34. PubMed ID: 25242402
[TBL] [Abstract][Full Text] [Related]
15. A toxicogenomic approach for the prediction of murine hepatocarcinogenesis using ensemble feature selection.
Eichner J; Kossler N; Wrzodek C; Kalkuhl A; Bach Toft D; Ostenfeldt N; Richard V; Zell A
PLoS One; 2013; 8(9):e73938. PubMed ID: 24040119
[TBL] [Abstract][Full Text] [Related]
16. Comparison of hepatocarcinogen-induced gene expression profiles in conventional primary rat hepatocytes with in vivo rat liver.
Doktorova TY; Ellinger-Ziegelbauer H; Vinken M; Vanhaecke T; van Delft J; Kleinjans J; Ahr HJ; Rogiers V
Arch Toxicol; 2012 Sep; 86(9):1399-411. PubMed ID: 22484513
[TBL] [Abstract][Full Text] [Related]
17. Opportunities for an alternative integrating testing strategy for carcinogen hazard assessment?
Doktorova TY; Pauwels M; Vinken M; Vanhaecke T; Rogiers V
Crit Rev Toxicol; 2012 Feb; 42(2):91-106. PubMed ID: 22141324
[TBL] [Abstract][Full Text] [Related]
18. Application of toxicogenomics to study mechanisms of genotoxicity and carcinogenicity.
Ellinger-Ziegelbauer H; Aubrecht J; Kleinjans JC; Ahr HJ
Toxicol Lett; 2009 Apr; 186(1):36-44. PubMed ID: 18822359
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens II. Further analysis of mammalian cell results, relative predictivity and tumour profiles.
Kirkland D; Aardema M; Müller L; Makoto H
Mutat Res; 2006 Sep; 608(1):29-42. PubMed ID: 16769241
[TBL] [Abstract][Full Text] [Related]
20. A novel, integrated in vitro carcinogenicity test to identify genotoxic and non-genotoxic carcinogens using human lymphoblastoid cells.
Wilde EC; Chapman KE; Stannard LM; Seager AL; Brüsehafer K; Shah UK; Tonkin JA; Brown MR; Verma JR; Doherty AT; Johnson GE; Doak SH; Jenkins GJS
Arch Toxicol; 2018 Feb; 92(2):935-951. PubMed ID: 29110037
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
